Rare diseases
Investigational molecules
Locations
Back to Germany1 786 clinical trials in Berlin, Germany across 17 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study of Ivosidenib for Patients with Previously Treated Advanced or Metastatic Cholangiocarcinoma
GermanyStudy Comparing MK-7684A (Vibostolimab and Pembrolizumab) with Pembrolizumab for Adults and Children with High-Risk Melanoma
GermanyStudy Comparing Imlunestrant with Standard Endocrine Therapy for Patients with Early ER+, HER2- Breast Cancer at Increased Risk of Recurrence
GermanyStudy on the Safety and Effects of Resatorvid and Filgrastim for Patients with Severe Alcoholic Hepatitis and Acute-on-Chronic Liver Failure
GermanyStudy on HIV-1 Treatment for Patients New to Therapy: Comparing Doravirine/Islatravir with a Drug Combination
GermanyStudy on Switching HIV Treatment to Doravirine and Islatravir for Patients with HIV-1
GermanyStudy on Doravirine and Islatravir for People with HIV-1 Previously Treated with the Same Drug Combination
GermanyStudy of Cytarabine and Daunorubicin for Treating Myeloid Leukemia in Children with Down Syndrome
GermanyStudy on Renaparin for Improving Kidney Function in Patients with End-Stage Renal Disease Receiving Deceased Donor Transplants
GermanyStudy of ipatasertib with atezolizumab and chemotherapy in women with triple-negative breast cancer before surgery
GermanyStudy on Melphalan and Drug Combination for Low and Intermediate Risk Neuroblastoma Patients
GermanyStudy on Lorundrostat for Patients with Uncontrolled and Resistant Hypertension
GermanyThe busiest research cities in the country
What the registry says about research in the country
Advanced clinical trials focusing on various cancer treatments, including studies of metastatic prostate cancer, colorectal cancer, and innovative approaches for breast cancer treatment.
Novel combination therapies and targeted treatments are being evaluated to improve patient outcomes across multiple cancer types.
Comprehensive vaccine development programs targeting various viral infections, including studies on respiratory syncytial virus, cytomegalovirus, and herpes zoster.
These trials aim to enhance immune response and provide long-term protection against serious viral infections.
Innovative treatments for various chronic conditions, including autoimmune dementia, hypertriglyceridemia, and studies in transplant medicine.
Research focuses on developing targeted therapies and improving treatment outcomes for long-term conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
